MoonLake Immunotherapeutics starts Phase 3 IZAR program of the Nanobody® sonelokimab in patients with active psoriatic arthritis Two trials for active psoriatic arthritis (PsA) with one focusing on ...
DelveInsight's Dermatological Drugs Market Insights report provides the current and forecast market analysis, individual ...
BioNTech said that it is acquiring the Chinese drugmaker Biotheus for $800 million to bolster its cancer strategy. The two ...
As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...
Researchers at the University of Massachusetts Amherst have invented a new, sprayable delivery system for psoriasis ...
Researchers have developed a patch for easier and more effective treatment of psoriasis. The method may also be used in treatment of other inflammatory skin diseases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback